Venture investors in Cambridge, Massachusetts
Updated 16 Nov 2026
Venture funds
5 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Founder Collective Founder Collective backs seed-stage startups, with recent investments including Baselayer, WHOOP and Ownwell. Cambridge, United States |
Artificial intelligence, Commerce | Seed, Early stage venture, Late stage venture | 6% | 5 |
| 2 | Mission BioCapital Mission BioCapital invests in early-stage life science companies, with recent investments including Circle Pharma and Cloverleaf Bio. Cambridge, United States |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 20% | 4 |
| 3 | F-Prime F-Prime invests in healthcare and technology, with recent companies including Albert Invent and Nocion Therapeutics. Cambridge, United States |
Health care, Fintech | Seed, Early stage venture, Late stage venture | 25% | 4 |
| 4 | Matrix Matrix invests in early-stage technology startups, with recent companies including Houmo.AI and Luma AI. Cambridge, United States |
Hardware, Artificial intelligence | Seed, Early stage venture | 32% | 4 |
| 5 | Engine Ventures Engine Ventures backs companies developing technologies for scientific and engineering problems, with recent companies including Trener Robotics and Addis Energy. Cambridge, United States |
Artificial intelligence, Biotech | 52% | 2 |
Table 1. Venture investors in Cambridge, Massachusetts: venture capital and micro VC funds ranked by companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Atlas Venture | Venture capital firm | Cambridge, United States | •••@atlasventure.com | 857 20••• |
| Founder Collective | Venture capital firm | Cambridge, United States | •••@foundercollective.com | (617) ••• |
| F-Prime | Venture capital firm | Cambridge, United States | •••@fprimecapital.com | |
| Accomplice | Family office | Cambridge, United States | •••@accomplice.co | 617-58••• |
| SBXi | Venture capital firm | Cambridge, United States | •••@sbxi.com | |
| Sanofi Ventures | Corporate venture arm | Cambridge, United States | •••@gmail.com | +1 617••• |
| E14 Fund | Micro VC fund | Cambridge, United States | •••@e14fund.com | +1 617••• |
| Flint Capital | Venture capital firm | Cambridge, United States | •••@flintcap.com |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
| Firm | Person | Title | Verified email | |
|---|---|---|---|---|
| Atlas Venture | B••• B••• | Partner | b•••@atlasventure.com | In the CSV |
| Matrix | D••• S••• | General Partner | d•••@matrix.vc | In the CSV |
| Founder Collective | A••• H••• | General Partner | a•••@foundercollective.com | In the CSV |
| F-Prime | S••• J••• | General Partner and Co-Founder, Investing in AI Native Software | s•••@fprimecapital.com | In the CSV |
| Accomplice | S••• A••• D••• | Operating Partner | s•••@accomplice.co | In the CSV |
5 verified partner contact rows from organizations on this list, names and emails masked.
- 18 of the 35 venture investors in Cambridge, Massachusetts have a published email address, 19 a phone number and 28 a website.
- Atlas Venture has the most recorded investments, 638, 179 of them as lead investor.
- 12 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Founder Collective is an investor in 5 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is T-Therapeutics' $133.0M Series B on 5 November 2026.
- Software is the most common sector across their 509 portfolio companies (78%).
- Early stage venture is the most common investment stage, recorded for 33 of them (94%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Venture investors in Cambridge, Massachusetts
28 of 35, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Atlas Venture | Venture capital firm | Cambridge, United States | Health care, Biotech | Diagonal Therapeutics | 1 | 638 | 179 | 199 | •••@atlasventure.com | 857 20••• | In the CSV |
| 2 | Matrix | Venture capital firm | Cambridge, United States | Hardware, Artificial intelligence | Houmo.AI, Ampersand, Outset | 4 | 585 | 190 | 151 | (617) ••• | In the CSV | |
| 3 | Founder Collective | Venture capital firm | Cambridge, United States | Artificial intelligence, Commerce | Baselayer, WHOOP, Ownwell | 5 | 543 | 35 | 161 | •••@foundercollective.com | (617) ••• | In the CSV |
| 4 | F-Prime | Venture capital firm | Cambridge, United States | Health care, Fintech | T-Therapeutics, Albert Invent, Immuneel Therapeutics | 4 | 540 | 133 | 113 | •••@fprimecapital.com | In the CSV | |
| 5 | Accomplice | Family office, Venture capital firm | Cambridge, United States | Fintech, Artificial intelligence | Veera | 1 | 386 | 101 | 88 | •••@accomplice.co | 617-58••• | In the CSV |
| 6 | Flagship Pioneering | Venture capital firm | Cambridge, United States | Biotech, Health care | Inari, Prologue Medicines, Quotient Therapeutics | 288 | 104 | 72 | 617-86••• | In the CSV | ||
| 7 | SR One | Venture capital firm | Cambridge, United States | Biotech, Health care | Asceneuron | 214 | 69 | 69 | (610) ••• | In the CSV | ||
| 8 | SBXi | Venture capital firm | Cambridge, United States | Health care, Hardware | SPORO Health, XanderGlasses, Basalt Tech | 196 | 0 | 6 | •••@sbxi.com | In the CSV | ||
| 9 | Sanofi Ventures | Corporate venture arm | Cambridge, United States | Biotech, Health care | i2o Therapeutics, Tisento Therapeutics, NGI | 119 | 31 | 28 | •••@gmail.com | +1 617••• | In the CSV | |
| 10 | E14 Fund | Micro VC fund | Cambridge, United States | Artificial intelligence, Hardware | Ramona | 1 | 112 | 12 | 11 | •••@e14fund.com | +1 617••• | In the CSV |
| 11 | Flint Capital | Venture capital firm | Cambridge, United States | Artificial intelligence, Hardware | Bluebricks, Antidote Health, Nokod Security | 101 | 36 | 18 | •••@flintcap.com | In the CSV | ||
| 12 | Mission BioCapital | Venture capital firm | Cambridge, United States | Biotech, Health care | Circle Pharma, Cloverleaf Bio, Integrated Biosciences | 4 | 85 | 17 | 19 | •••@missionbiocapital.com | +1 617••• | In the CSV |
| 13 | Safar Partners | Private equity firm, Venture capital firm | Cambridge, United States | Biotech, Health care | Gelmedix | 1 | 85 | 17 | 7 | •••@safar.partners | (646) ••• | In the CSV |
| 14 | HubSpot Ventures | Corporate venture arm | Cambridge, United States | Artificial intelligence, Commerce | Agency AI, Artisan AI, doola | 64 | 12 | 8 | •••@hubspot.com | +1 888••• | In the CSV | |
| 15 | Converge | Venture capital firm | Cambridge, United States | Artificial intelligence, Fintech | Zenskar | 1 | 55 | 4 | 8 | (617) ••• | In the CSV | |
| 16 | MRL Ventures Fund | Corporate venture arm, Venture capital firm | Cambridge, United States | Biotech, Health care | InduPro | 1 | 52 | 8 | 14 | In the CSV | ||
| 17 | Rhapsody Venture Partners | Venture capital firm | Cambridge, United States | Hardware, Artificial intelligence | Polaris Electro-Optics | 1 | 46 | 25 | 2 | •••@rhapsodyvp.com | In the CSV | |
| 18 | Tectonic Ventures | Venture capital firm | Cambridge, United States | Artificial intelligence, Hardware | Marveri, Humatics, OmniML | 43 | 3 | 4 | In the CSV | |||
| 19 | Engine Ventures | Venture capital firm | Cambridge, United States | Artificial intelligence, Biotech | Trener Robotics, Addis Energy | 2 | 42 | 22 | 1 | •••@engineventures.com | 617-54••• | In the CSV |
| 20 | Action Potential Venture Capital | Venture capital firm | Cambridge, United States | Health care | Presidio Medical | 30 | 5 | 3 | (888) ••• | In the CSV | ||
| 21 | Rivas Capital | Venture capital firm | Cambridge, United States | Artificial intelligence, Biotech | ReviveMed, Comgy | 25 | 5 | 5 | (857) ••• | In the CSV | ||
| 22 | Yonjin Venture | Venture capital firm | Cambridge, United States | 24 | 5 | 7 | •••@yjventure.com | (657) ••• | ||||
| 23 | Blue Haven Initiative | Micro VC fund, Venture capital firm | Cambridge, United States | Fintech | Umati Capital, SmartProcure | 23 | 6 | 3 | •••@bluehaveninitiative.com | 857 24••• | In the CSV | |
| 24 | Joint Effects | Venture capital firm | Cambridge, United States | Software | Trident Digital, Authentic Vision | 13 | 3 | 1 | In the CSV | |||
| 25 | Gurnet Point Capital | Private equity firm, Venture capital firm | Cambridge, United States | Health care, Artificial intelligence | Fairtility, BEFORE Brands | 12 | 9 | 2 | •••@gurnetpointcapital.com | 617-58••• | In the CSV | |
| 26 | Forma Prime | Venture capital firm | Cambridge, United States | 4 | 0 | 1 | In the CSV | |||||
| 27 | EST Global | Corporate venture arm | Cambridge, United States | Artificial intelligence, Hardware | RAI, DR. PECKER | 3 | 2 | 0 | •••@estgrp.net | +1 786••• | In the CSV | |
| 28 | EGI Capital | Private equity firm, Venture capital firm | Cambridge, United States | 0 | 0 | 0 | •••@egicapital.biz | In the CSV |
Table 2. Venture investors in Cambridge, Massachusetts: the first 28 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 35.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Founder Collective | Cambridge, United States | 5 | 119 | Baselayer, WHOOP, Ownwell |
| 2 | F-Prime | Cambridge, United States | 4 | 75 | T-Therapeutics, Albert Invent, Immuneel Therapeutics |
| 3 | Matrix | Cambridge, United States | 4 | 109 | Houmo.AI, Ampersand, Outset |
| 4 | Mission BioCapital | Cambridge, United States | 4 | 8 | Circle Pharma, Cloverleaf Bio, Integrated Biosciences |
| 5 | Engine Ventures | Cambridge, United States | 2 | 7 | Trener Robotics, Addis Energy |
| 6 | E14 Fund | Cambridge, United States | 1 | 20 | Ramona |
| 7 | Rhapsody Venture Partners | Cambridge, United States | 1 | 3 | Polaris Electro-Optics |
| 8 | MRL Ventures Fund | Cambridge, United States | 1 | 3 | InduPro |
| 9 | Converge | Cambridge, United States | 1 | 10 | Zenskar |
| 10 | Safar Partners | Cambridge, United States | 1 | 4 | Gelmedix |
| 11 | Accomplice | Cambridge, United States | 1 | 47 | Veera |
| 12 | Atlas Venture | Cambridge, United States | 1 | 47 | Diagonal Therapeutics |
Table 3. Venture investors in Cambridge, Massachusetts: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge, United Kingdom | Series B | $133.0M | 2026-11-05 | $224.6M | F-Prime | 51 to 100 | 2022 |
| Albert Invent | Albert Invent builds an AI platform that supports chemistry research and development for scientific and industrial users. | Artificial intelligence | Oakland, United States | Series B | $55.0M | 2026-10-13 | $105.0M | F-Prime | 101 to 250 | 2022 |
| Ampersand | Ampersand provides integration infrastructure for enterprise AI agents and software applications. | Artificial intelligence | San Francisco, United States | Series A | $15.0M | 2026-10-06 | $19.7M | Matrix | 11 to 50 | 2022 |
| Baselayer | Baselayer automates risk assessment and fraud detection for financial and government institutions. | Artificial intelligence | New York, United States | Series A | $35.0M | 2026-09-22 | $82.0M | Founder Collective | 51 to 100 | 2024 |
| Ramona | Ramona develops high-throughput microscopy tools for biology labs. | Artificial intelligence | Durham, United States | Series A | $25.0M | 2026-09-22 | $59.7M | E14 Fund | 11 to 50 | 2017 |
| Circle Pharma | Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. | Biotech | South San Francisco, United States | Series E | $92.5M | 2026-09-16 | $300.0M | Mission BioCapital | 11 to 50 | 2012 |
| Polaris Electro-Optics | Polaris Electro-Optics develops integrated photonics for communications and computation. | Hardware | Broomfield, United States | Series B | $50.0M | 2026-09-15 | $63.2M | Rhapsody Venture Partners | 11 to 50 | 2021 |
| Cloverleaf Bio | Cloverleaf Bio develops an RNA therapeutic platform for oncology. | Biotech | New Haven, United States | Seed | $33.0M | 2026-09-08 | $33.0M | Mission BioCapital | 1 to 10 | 2023 |
| InduPro | InduPro develops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease. | Biotech | Seattle, United States | Series B | $77.0M | 2026-08-12 | $162.0M | MRL Ventures Fund | 51 to 100 | 2022 |
| Integrated Biosciences | Integrated Bio develops multimodal biological datasets and AI for drug discovery against age-related diseases. | Artificial intelligence | Redwood City, United States | Series A | $68.4M | 2026-08-05 | $85.6M | Mission BioCapital | 11 to 50 | 2022 |
Table 4. Venture investors in Cambridge, Massachusetts: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 397 | 78% |
| Artificial intelligence | 97 | 19% |
| Hardware | 86 | 17% |
| Health care | 83 | 16% |
| Fintech | 62 | 12% |
| Biotech | 50 | 10% |
| Commerce | 45 | 9% |
| Cybersecurity | 39 | 8% |
| Education | 19 | 4% |
| Energy | 4 | 1% |
Table 5. Venture investors in Cambridge, Massachusetts: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Venture investors | 35 | 100% |
| Early stage investors | 33 | 94% |
| Seed investors | 27 | 77% |
| Late stage investors | 23 | 66% |
| Post IPO investors | 7 | 20% |
| Convertible note investors | 7 | 20% |
| Private equity investors | 5 | 14% |
| Debt investors | 3 | 9% |
Table 6. Venture investors in Cambridge, Massachusetts by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 2 | 7% |
| 2010s | 17 | 63% |
| 2000s | 4 | 15% |
| 1980s | 2 | 7% |
| 1970s | 1 | 4% |
| 1940s | 1 | 4% |
Table 7. Venture investors in Cambridge, Massachusetts by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its recorded investment stages include venture investors and its headquarters is in Cambridge, Massachusetts. On 16 November 2026 that is 35 investors.
- 18 rows carry an email address and 19 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 28 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 35 rows: 7 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many venture investors in Cambridge, Massachusetts are on the list?
- 35, in the file dated 16 November 2026. 12 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 18 of the 35 carry an email address in the download and 19 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 35 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 35 rows, 18 firm email addresses and 19 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 12 of the 18 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.